derived from maintaining balance, stabilizing the
body, absorbing and releasing energy, achieving
force transmission and tiptoeing. In daily life, it is
specifically reflected in running, jumping, walking
and all other activities that require the body to move
forward or upward.
One of the best standards for measuring Achilles
tendon and ankle function is the VISA-A. The VISA-
A(Victorian Institute of Sport Assessment–Achilles)
is a validated questionnaire designed to assess the
severity of Achilles tendinopathy. It consists of 8
items covering pain, function in daily living, and
sporting activity. Scores range from 0 to 100, with
higher scores indicating better function and fewer
symptoms. A score of ≥90 is commonly used to
indicate readiness to return to sport (Silbernagel and
Crossley,2015).
In a retrospective cohort study, after treatment
with radial shockwave therapy (n = 58) or combined
radial and focused shockwave therapy (n = 29) for
patients with Achilles tendinopathy refractory to
exercise therapy, it was demonstrated overall
functional improvement for both groups. Besides, it
is suggested that combined radial and focused
shockwave therapy may provide more predictable
functional gains for treatment of Achilles
tendinopathy compared to radial shockwave therapy
(Robinson et al.,2022).
2.3 Anti-inflammatory Effect
Inflammation is often present to varying degrees in
Achilles tendinopathy, commonly referred to as
Achilles tendonitis. Many symptoms, including
discomfort, swelling, warmth, and pain, are
attributable to inflammatory processes. Therefore, for
any therapeutic intervention to be effective in treating
Achilles tendon disorders, anti-inflammatory effects
are essential. However, there are very few clinical
studies and literatures, especially after 2020, to study
the anti-inflammatory effects of the shock wave
therapy of Achilles tendon disease. However, many
articles have discussed the anti-inflammatory effect
of shock wave therapy and explained its mechanism.
Therefore, at the same time, the materials cited in this
chapter are relatively special and are not entirely
literature after 2020 and clinical practice. As
highlighted in this concise review, a potential
molecular mechanism underlying the anti-
inflammatory effects of extracorporeal shock waves
(ESWs) appears to involve the maintenance of local
nitric oxide (NO) concentrations within physiological
ranges during the early phase of the inflammatory
response. This effect may be mediated through the
facilitation of both enzymatic and non-enzymatic
pathways of NO molecule production (Mariotto et
al.,2009). ESWT, therefore, has great potential to be
applied in an increasing number of inflammatory
diseases in the future.
No matter how effective a treatment may be, the
emergence of adverse side effects warrants serious
attention from both researchers and healthcare
professionals. Over the past five years, few clinical
studies and corresponding publications have
specifically focused on the adverse effects of
shockwave therapy. Nonetheless, a considerable
number of clinical reports have included discussions
on treatment-related side effects. Most of these
studies reported no observable adverse reactions
attributable to shockwave therapy throughout the
research period. However, some accounts have noted
the occurrence of typical side effects associated with
extracorporeal shockwave therapy (ESWT), which
were generally limited to localized skin erythema,
mild bruising, swelling, pain, numbness, or tingling
sensations within or around the treatment area during
or within 24 hours post-treatment (Crevenna et
al.,2021). Other types of adverse reactions were
rarely documented. The most effective approach to
mostly avoiding side effects remains the strict
adherence to contraindication guidelines.
Extracorporeal shock wave therapy should be
contraindicated or used with caution under the
following conditions: pregnancy (particularly when
the treatment area is near the abdomen or pelvic
region); the presence of bleeding disorders or
ongoing use of anticoagulant medications; localized
infections or malignancies at the treatment site; and
patients with implanted cardiac pacemakers
(depending on the type of device).Overall, shock
wave therapy is a treatment with relatively few side
effects and can be regarded as a safe method.
3 LIMITATIONS
The analysis and synthesis presented in this study are
reasonably systematic. However, aside from the
illustrative references explicitly discussed, the
number of underlying studies identified and reviewed
is fewer than ten. This limited scope of literature
somewhat undermines the robustness of clinical
evidence supporting each specific shockwave therapy
system. Additionally, the study does not provide a
comprehensive exploration of the underlying
mechanisms through which various types of
shockwave therapy exert their therapeutic effects;